Physician

Milan Shah, M.D.

According to 2025 Medicare claims, Milan Shah, M.D. (NPI: 1104901644) practices ophthalmology in the Indianapolis-Carmel-Greenwood, IN market, with the plurality of this provider's patient population coming from Marion, IN. This provider's primary affiliated billing organization is MIDWEST EYE RETINA PC (NPI: 1851686968; TIN: 451872257) and primary practice location at 46143-6274.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 655 traditional Medicare patients, billed 16,168 HCPCS/CPT codes, and received $1,831,349 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,297 prescription claims across 325 beneficiaries totaling $139,397 in drug costs, led by Ilevro (Nepafenac). Open Payments data shows 16 records totaling $61,569. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	865	10,757	$1,410,962
2016	1,115	12,925	$1,660,484
2017	1,075	12,938	$1,772,837
2018	995	11,306	$1,599,081
2019	949	11,391	$1,658,037
2020	808	9,607	$1,536,373
2021	798	9,547	$1,667,284
2022	768	9,116	$1,627,659
2023	715	9,744	$1,639,888
2024	655	16,168	$1,831,349

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	235	888	$85,767
2016	285	1,192	$137,705
2017	305	1,420	$180,179
2018	307	1,279	$168,790
2019	335	1,332	$184,751
2020	325	1,507	$202,836
2021	310	1,331	$172,540
2022	344	1,479	$179,610
2023	338	1,406	$180,477
2024	325	1,297	$139,397

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	164	275	$98
67028	Injection of drug into eye	301	1,585	$96
J3590	Unclassified biologics	173	795	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	368	566	$66
92134	Imaging of retina	606	2,156	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ilevro	Nepafenac	138	5,230	$60,546
Prednisolone Acetate	Prednisolone Acetate	272	16,949	$12,954
Travoprost	Travoprost	72	4,978	$8,687
Difluprednate	Difluprednate	68	3,212	$6,730
Alphagan P	Brimonidine Tartrate	12	802	$5,888

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$681	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$60,888	Apellis Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Milan Shah, M.D.?

Tedicare shows public-source Medicare data for Milan Shah, M.D. (NPI 1104901644), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Milan Shah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Milan Shah, M.D.?

Milan Shah, M.D. is linked to MIDWEST EYE RETINA PC (billing NPI 1851686968) in the available physician profile data.

Does Milan Shah, M.D. have Open Payments data?

Milan Shah, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.